These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Synthetic Pot: Not Your Grandfather's Marijuana. Ford BM; Tai S; Fantegrossi WE; Prather PL Trends Pharmacol Sci; 2017 Mar; 38(3):257-276. PubMed ID: 28162792 [TBL] [Abstract][Full Text] [Related]
6. Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. Rajasekaran M; Brents LK; Franks LN; Moran JH; Prather PL Toxicol Appl Pharmacol; 2013 Jun; 269(2):100-8. PubMed ID: 23537664 [TBL] [Abstract][Full Text] [Related]
7. Synthetic Cannabinoids. Mills B; Yepes A; Nugent K Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518 [TBL] [Abstract][Full Text] [Related]
8. The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products. Brents LK; Prather PL Drug Metab Rev; 2014 Feb; 46(1):72-85. PubMed ID: 24063277 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites. Tai S; Fantegrossi WE Curr Top Behav Neurosci; 2017; 32():249-262. PubMed ID: 28012093 [TBL] [Abstract][Full Text] [Related]
10. Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. Tai S; Fantegrossi WE Curr Addict Rep; 2014 Jun; 1(2):129-136. PubMed ID: 26413452 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154 [TBL] [Abstract][Full Text] [Related]
12. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects. Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336 [TBL] [Abstract][Full Text] [Related]
13. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. Brents LK; Reichard EE; Zimmerman SM; Moran JH; Fantegrossi WE; Prather PL PLoS One; 2011; 6(7):e21917. PubMed ID: 21755008 [TBL] [Abstract][Full Text] [Related]
14. Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids. Wiley JL; Owens RA; Lichtman AH Curr Top Behav Neurosci; 2018; 39():153-173. PubMed ID: 27278640 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Pacher P; Steffens S; Haskó G; Schindler TH; Kunos G Nat Rev Cardiol; 2018 Mar; 15(3):151-166. PubMed ID: 28905873 [TBL] [Abstract][Full Text] [Related]
16. Cannabis and Neuropsychiatric Disorders: An Updated Review. Chayasirisobhon S Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704 [TBL] [Abstract][Full Text] [Related]